WallStreetZenWallStreetZen

NASDAQ: PACB
Pacific Biosciences Of California Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Pacific Biosciences Of California revenue was $156.11M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $39.8M, up 7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PACB annual revenue was $154.0M, with -23.2% growth year-over-year.

PACB past revenue growth

How has PACB's revenue growth performed historically?

Company
-17.35%
Industry
10.69%
Market
19.58%
PACB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PACB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PACB's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PACB revenue history

Current Revenue
$156.1M
Current Earnings
-$526.4M
Current Profit Margin
-337.2%

Be the first to know when PACB announces revenue.

PACB Revenue History By Year

PACB Yearly RevenuePACB RevenuePACB ChangePACB Revenue Growth
2024-12-31$154.01M-$46.51M-23.19%
2023-12-31$200.52M$72.22M+56.29%
2022-12-31$128.30M-$2.21M-1.69%
2021-12-31$130.51M$51.62M+65.43%
2020-12-31$78.89M-$12.00M-13.20%
2019-12-31$90.89M$12.27M+15.60%
2018-12-31$78.63M-$14.84M-15.88%
2017-12-31$93.47M$2.75M+3.04%
2016-12-31$90.71M-$2.07M-2.23%
2015-12-31$92.78M$32.19M+53.12%
2014-12-31$60.59M$32.41M+115.02%
2013-12-31$28.18M$2.20M+8.46%
2012-12-31$25.98M-$7.88M-23.27%
2011-12-31$33.86M$32.19M+1,922.88%
2010-12-31$1.67M$1.54M+1,140.00%
2009-12-31$135.00k-$766.00k-85.02%
2008-12-31$901.00k-$1.26M-58.34%
2007-12-31$2.16MN/AN/A

1 of 2

Pacific Biosciences Of California Revenue FAQ

What was PACB's revenue last quarter?

On Invalid Date, Pacific Biosciences Of California (NASDAQ: PACB) reported Q2 2025 revenue of $39.77 million up 10.42% year over year. In the same quarter last year, Pacific Biosciences Of California's revenue was $36.01 million.

What was Pacific Biosciences Of California's revenue in 2024?

Pacific Biosciences Of California's annual revenue for the twelve months ending Dec 31, 2024 was $154.01 million, a 23.19% decrease year over year.

How much does Pacific Biosciences Of California make in a day?

Based on Pacific Biosciences Of California annual revenue for the past five years, PACB makes an average of $379,312.33 per day.

What was Pacific Biosciences Of California's annual revenue growth in the past year?

As of Q4 2025, Pacific Biosciences Of California's revenue has grown -17.35% year over year. This is 28.04 percentage points lower than the US Medical Devices industry revenue growth rate of 10.69%. Pacific Biosciences Of California's revenue in the past year totaled $156.11 million.

How much does Pacific Biosciences Of California make in a year?

Pacific Biosciences Of California's revenue by year for the past five years is:
  • Pacific Biosciences Of California's revenue for the twelve months ending Dec 31, 2024 was $154.01 million, a 23.19% decrease year over year.
  • Pacific Biosciences Of California's annual revenue for Dec 31, 2023 was $200.52 million, a 56.29% increase from 2022.
  • Pacific Biosciences Of California's annual revenue for 2022 was $128.30 million, a 1.69% decrease from 2021.
  • Pacific Biosciences Of California's annual revenue for 2021 was $130.51 million, a 65.43% increase from 2020.
  • Pacific Biosciences Of California's annual revenue for 2020 was $78.89 million, a 13.2% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.